Skip to content
Rameda Pharma
Rameda Pharma
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact
Corporate Website
  • ع
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact

Yearly Archives: 2022

You are here:
  1. Home
  2. 2022

Disclosure to EGX on Treasury Shares

Regulatory DisclosuresBy adminMarch 10, 2022

Disclosure to EGX on Treasury Shares

Regulatory DisclosuresBy adminMarch 10, 2022

Disclosure to EGX on Treasury Shares

Regulatory DisclosuresBy adminMarch 10, 2022

Disclosure on Rameda’s Organizational Framework

Regulatory DisclosuresBy adminMarch 9, 2022

Disclosure to EGX on the Purchase of Treasury Shares

Regulatory DisclosuresBy adminMarch 8, 2022

Rameda Reports its FY22 Results

Corporate NewsBy adminMarch 7, 2022

Equinox Pharma Holding Limited (Equinox), alongside other investors, further increases its stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.

Corporate NewsBy adminMarch 7, 2022

EGX Disclosure on shareholding structure

Regulatory DisclosuresBy adminMarch 6, 2022

EGX Disclosure on shareholding structure

Regulatory DisclosuresBy adminMarch 6, 2022

EGX disclosure regarding the upcoming OGM on 22 March 2022

Regulatory DisclosuresBy adminFebruary 27, 2022
←1
234
…56789→

All Rights Reserved © 2024

Go to Top